ניתוח אוטומטי בהחלפת מסתם אבי העורקים באמצעות צנתר במציאות רבודה

Executive Industry Relevance

Integrating augmented reality (AR) and robotics into transcatheter aortic valve replacement (TAVR) workflows addresses the need for precision, real-time visualization, and remote expert intervention in complex cardiovascular procedures. This approach enhances predictive confidence and operational efficiency at critical inflection points in device-based intervention pipelines. The system's real-time 3D reconstruction and remote control capabilities position it as a reusable platform for scalable, cross-site surgical innovation.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Enables precise interrogation of device-tissue interactions through real-time 3D visualization.
• Supports mechanistic de-risking by allowing remote experts to validate procedural steps and outcomes.
• Facilitates functional validation of robotic and AR-guided interventions in preclinical models.

Screening & Assay Development

• Prepares validated procedural testbeds for downstream device evaluation and optimization.
• Standardizes image capture and feature extraction for reproducible quantitative assessment.
• Enables scalable, remote-controlled assay environments for iterative device testing.

Translational & Preclinical Research

• Aligns procedural fidelity with disease-relevant anatomical models for translational continuity.
• Supports risk-adjusted advancement of AR-guided interventions from benchtop to preclinical validation.
• Provides a platform for benchmarking remote surgical guidance technologies in translational settings.

Pipeline & Workflow Integration

This AR-robotics platform bridges early device discovery, procedural validation, and translational research by enabling real-time, remote-controlled interventions and quantitative feedback loops.

• Discovery Biology: Supports hypothesis testing of device performance and procedural safety in controlled environments.
• Screening: Delivers standardized, reproducible image-based outputs for comparative device evaluation.
• Analytics: Provides quantitative 3D reconstructions and feature extraction for robust data analysis.
• Translational Research: Ensures procedural alignment with clinical models and supports biomarker-driven validation.
• Enterprise Reuse: Offers a modular, scalable platform adaptable to diverse device and procedural development pipelines.

Operational & Enterprise Impact

• Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in device-guided interventions.
• Operational Value: Enhances standardization, reproducibility, and remote scalability of procedural workflows.
• Strategic Value: Improves go/no-go decision-making and capital efficiency by enabling remote expert oversight.
• Portfolio Impact: Supports risk-adjusted prioritization and advancement of AR-enabled surgical technologies.

Implementation Considerations

• Requires expertise in AR, robotics, and real-time image analysis.
• Demands robust instrumentation and synchronized communication infrastructure.
• Necessitates cross-team standardization of image capture and feature extraction protocols.
• Adaptable across procedural models but may require calibration for specific anatomical contexts.
• Latency and motion-mapping accuracy are practical limitations to monitor during deployment.

Biopharma FAQs